DISCUSSION

Cells derived from iPSC can be immunogenic — Yes or No?

  • Jiani Cao ,
  • Xiaoyan Li ,
  • Xiao Lu ,
  • Chao Zhang ,
  • Honghao Yu ,
  • Tongbiao Zhao
Expand
  • State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China

Published date: 01 Jan 2014

Copyright

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming factors in somatic cells, can potentially provide unlimited autologous cells for regenerative medicine. In theory, the autologous cells derived from patient iPSCs should be immune tolerant by the host without any immune rejections. However, our recent studies have found that even syngeneic iPSC-derived cells can be immunogenic in syngeneic hosts by using a teratoma transplantation model (Nature 474:212–215, 2011). Recently two research groups differentiated the iPSCs into different germ layers or cells, transplanted those cells to the syngeneic hosts, and evaluated the immunogenicity of those cells. Both of the two studies support our conclusions that some certain but not all tissues derived from iPSCs can be immunogenic, although they claimed either “negligible” or “lack of” immunogenicity in iPSC derivatives (Nature 494:100–104, 2013; Cell Stem Cell 12:407–412, 2013). To test the immunogenicity of clinically valuable cells differentiated from human iPSCs are emergently required for translation of iPSC technology to clinics.

Cite this article

Jiani Cao , Xiaoyan Li , Xiao Lu , Chao Zhang , Honghao Yu , Tongbiao Zhao . Cells derived from iPSC can be immunogenic — Yes or No?[J]. Protein & Cell, 2014 , 5(1) : 1 -3 . DOI: 10.1007/s13238-013-0003-2

1
ArakiR, UdaM, HokiY, SunayamaM, NakamuraM (2013) Nature494: 100-104

DOI

2
ChiJG, LeeYS, ParkYS, ChangKY (1984) Am J Clin Pathol82: 115-119

3
DoiA, ParkIH, WenB, MurakamiP, AryeeMJ (2009) Nat Genet41: 1350-1353

DOI

4
GoreA, LiZ, FungHL, YoungJE, AgarwalS (2011) Nature471: 63-67

DOI

5
GuhaP, MorganJW, MostoslavskyG, RodriguesNP, BoydAS (2013) Cell Stem Cell12: 407-412

DOI

6
KimK, DoiA, WenB, NgK, ZhaoR (2010) Nature467: 285-290

DOI

7
KochCA, GeraldesP, PlattJL (2008) Stem Cells26: 89-98

DOI

8
ListerR, PelizzolaM, KidaYS, HawkinsRD, NeryJR (2011) Nature471: 68-73

DOI

9
PoloJM, LiuS, FigueroaME, KulalertW, EminliS (2010) Nat Biotechnol28: 848-855

DOI

10
TakahashiK, YamanakaS (2006) Cell126: 663-676

DOI

11
TapperD, LackEE (1983) Ann Surg198: 398-410

DOI

12
ZhaoT, XuY (2010) Trends Cell Biol20: 170-175

DOI

13
ZhaoT, ZhangZN, RongZ, XuY (2011) Nature474: 212-215

DOI

Outlines

/